Aggregated data drug information system (ADDIS) is a software tool that supports evidence-based decision-making in different healthcare settings by helping regulators link their decisions to the underlying evidence. ADDIS originates from the Escher Project work package 3.2. In 2013, an initiative was started to bring the software onto the market based around a sustainable user platform to become a self-reliant entity for use in healthcare.
Exon Consultancy performed a market analysis to identify the most feasible opportunities in which the software can be exploited within the healthcare sector. Based on the market analysis, we developed a sustainable strategy that fits the vision and ambition of ADDIS, which was translated into a business plan for the valorisation of ADDIS.